DNAPrint Genomics Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
25
- Stock Symbol
-
DNAG
- Investments
-
1
DNAPrint Genomics General Information
Description
DNA Print Genomics Inc is a pharmaceutical company that focuses on the human genome sciences. Through its subsidiaries, it is into research and development of genomic products and provides scientific services and tests to the genealogy, forensic, pharmaceutical, and genetics markets; and focuses on personalized medicine; and other operations.
Contact Information
Corporate Office
- 1621 West University Parkway
- Sarasota, FL 34243
- United States
Corporate Office
- 1621 West University Parkway
- Sarasota, FL 34243
- United States
DNAPrint Genomics Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| 1K |
DNAPrint Genomics Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2007 | FY 2006 31-Dec-2006 | FY 2005 31-Dec-2005 | FY 2004 31-Dec-2004 |
|---|---|---|---|---|
| EV | 8,275 | |||
| Revenue | 1,931 | 2,433 | 1,276 | 786 |
| Net Income | (4,551) | (12,348) | (8,716) | (3,735) |
| Total Assets | 3,113 | 10,270 | 6,310 | 1,791 |
| Total Debt | 5,328 | 7,283 | 1,070 | 628 |
DNAPrint Genomics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DNAPrint Genomics Patents
DNAPrint Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20080027756-A1 | Systems and methods for identifying and tracking individuals | Inactive | 30-Jun-2006 | 000000000 | 0 |
| CA-2598455-A1 | Multiplex assays for inferring ancestry | Inactive | 18-Feb-2005 | 0000000000 | |
| EP-1853730-A2 | Multiplex assays for inferring ancestry | Inactive | 18-Feb-2005 | 0000000000 | |
| AU-2006214039-A1 | Multiplex assays for inferring ancestry | Inactive | 18-Feb-2005 | 0000000000 | |
| CA-2588077-A1 | Compositions and methods for inferring an adverse effect in response to a drug treatment | Inactive | 12-Nov-2004 | C12Q1/6883 |
DNAPrint Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
DNAPrint Genomics Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Biofrontera (Germany) | 04-Nov-2004 | 00000 0000 | 000.00 | Pharmaceuticals |
DNAPrint Genomics Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Biofrontera (Germany) | 04-Nov-2004 | 00000 00000 | 000.00 | Completed |
|
DNAPrint Genomics FAQs
-
When was DNAPrint Genomics founded?
DNAPrint Genomics was founded in 1983.
-
Where is DNAPrint Genomics headquartered?
DNAPrint Genomics is headquartered in Sarasota, FL.
-
What is the size of DNAPrint Genomics?
DNAPrint Genomics has 25 total employees.
-
What industry is DNAPrint Genomics in?
DNAPrint Genomics’s primary industry is Biotechnology.
-
Is DNAPrint Genomics a private or public company?
DNAPrint Genomics is a Public company.
-
What is DNAPrint Genomics’s stock symbol?
The ticker symbol for DNAPrint Genomics is DNAG.
-
What is DNAPrint Genomics’s current revenue?
The trailing twelve month revenue for DNAPrint Genomics is $1.93M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
